| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/05/2007 | CA2634999A1 Muscarinic agonists and methods of use thereof |
| 07/05/2007 | CA2634456A1 Modulators of muscarinic receptors |
| 07/05/2007 | CA2634255A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 07/05/2007 | CA2634139A1 Omega 3 fatty acid formulations |
| 07/05/2007 | CA2634112A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| 07/05/2007 | CA2634111A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 07/05/2007 | CA2634110A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 07/05/2007 | CA2634088A1 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 07/05/2007 | CA2633653A1 Heterocyclic derivatives as modulators of ion channels |
| 07/05/2007 | CA2633536A1 Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives |
| 07/05/2007 | CA2633356A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803722A1 Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 07/04/2007 | EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2007 | EP1803718A1 4-Tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 07/04/2007 | EP1803460A1 Composition and method for therapy or prevention of mental symptom |
| 07/04/2007 | EP1803451A1 Pufa supplements |
| 07/04/2007 | EP1803448A2 Tasted masked veterinary solid compositions |
| 07/04/2007 | EP1802660A2 Methods of using death receptor ligands and cd20 antibodies |
| 07/04/2007 | EP1802631A2 Thienopyridinone compounds and methods of treatment |
| 07/04/2007 | EP1802627A1 Pyrazolo (1,5-alpha) pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 07/04/2007 | EP1802616A1 Novel azabicyclic aryl derivatives and their medical use |
| 07/04/2007 | EP1802615A1 Phosphodiesterase 4 inhibitors |
| 07/04/2007 | EP1802612A1 Novel b1 bradykinin receptor antagonists |
| 07/04/2007 | EP1802601A1 Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity |
| 07/04/2007 | EP1802598A2 Asymmetric synthesis of dihydrobenzofuran derivatives |
| 07/04/2007 | EP1802597A1 Asymmetric synthesis of substituted dihydrobenzofurans |
| 07/04/2007 | EP1802588A1 Substituted amino-pyrimidones and uses thereof |
| 07/04/2007 | EP1802587A1 Substituted amino-compounds and uses thereof |
| 07/04/2007 | EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 07/04/2007 | EP1802578A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 07/04/2007 | EP1802575A1 Polymorph of n,n-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
| 07/04/2007 | EP1802574A2 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 07/04/2007 | EP1802372A2 Cgrp receptor antagonists |
| 07/04/2007 | EP1802320A1 Pharmaceutical canscora diffusa-containing composition |
| 07/04/2007 | EP1802313A2 Therapeutic agents trageting the ncca-atp channel and methods of use thereof |
| 07/04/2007 | EP1802307A1 Pyrrolidine derivatives as histamine receptors ligands |
| 07/04/2007 | EP1802301A1 Treatment of bipolar disorders and associated symptoms |
| 07/04/2007 | EP1802294A1 Carbamate compounds for use in treating neurodegenerative disorders |
| 07/04/2007 | EP1802276A1 Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| 07/04/2007 | EP1603564B1 Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic neuropathological or psychogenic pain symptoms |
| 07/04/2007 | EP1569636A4 Use of equol for treating androgen mediated diseases |
| 07/04/2007 | EP1539751A4 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides |
| 07/04/2007 | EP1456189B1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/04/2007 | EP1397128B1 Kappa opoid agonist for the treatment of irritable bladder |
| 07/04/2007 | EP1339411B1 Use of zoledronic acid for pain treatment |
| 07/04/2007 | EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 07/04/2007 | EP1260512B1 Novel cyclic amide derivatives |
| 07/04/2007 | EP1194560B1 Antigenic neisserial peptides |
| 07/04/2007 | EP1161449B1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 07/04/2007 | EP1034301B1 Inhibition of an fgf-binding protein using ribozymes |
| 07/04/2007 | CN1993463A Follistatin mutant polypeptide |
| 07/04/2007 | CN1993343A Tetracyclic compounds as estrogen ligands |
| 07/04/2007 | CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 07/04/2007 | CN1993338A Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 07/04/2007 | CN1993330A Quinoline derivatives as neurokinin receptor antagonists |
| 07/04/2007 | CN1993329A Quinoline derivatives as neurokinin receptor antagonists |
| 07/04/2007 | CN1993325A Piperidine derivatives as histamine h3 receptor ligands |
| 07/04/2007 | CN1993324A 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 07/04/2007 | CN1993319A Benzyloxy derivatives as MAOB inhibitors |
| 07/04/2007 | CN1993143A Method for treating multiple sclerosis |
| 07/04/2007 | CN1993120A Arylacetic acids and related compounds for treatment of alzheimer's disease |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990485A Silybin flavonolignan and their production method and use |
| 07/04/2007 | CN1990481A Scutellarein derivative, its preparing process and application |
| 07/04/2007 | CN1990480A Compound promoting neurocyte growth |
| 07/04/2007 | CN1990478A 6-aryl-3-substituted methylene pyranone compounds, preparation process and use thereof |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1990471A Mch antagonists and their use in the treatment of obesity |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990446A Chalcone compound, its preparing method, compound comprising same and use thereof |
| 07/04/2007 | CN1990036A Paraplegia treating Chinese traditional medicine |
| 07/04/2007 | CN1990035A Paraplegia treating Chinese traditional medicine |
| 07/04/2007 | CN1990021A Brain function promoting agent |
| 07/04/2007 | CN1990011A Dripping pills for improving sleep quality and its preparation process |
| 07/04/2007 | CN1989988A Acanthopanax root dispersed tablet |
| 07/04/2007 | CN1989974A Freeze dried injection for treating cerebral apoplexy and its after-effect and its preparation method |
| 07/04/2007 | CN1989968A Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 07/04/2007 | CN1324017C Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
| 07/04/2007 | CN1324013C Aryl Fused azapolycyclic compounds |
| 07/04/2007 | CN1324011C Azaspiro compounds for the treatment of pain |
| 07/04/2007 | CN1324004C New phenyl-naphthalene derivatives, and preparation method and drug containing same |
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands |
| 07/04/2007 | CN1323686C Detoxifying sobering up tea and its production method |
| 07/04/2007 | CN1323663C Sustained-release tablet comprising reboxetine |
| 07/04/2007 | CN1323659C New usage of agmatine |
| 07/04/2007 | CN1323657C High efficioncy stop smoking buccal tablets |
| 07/04/2007 | CN1323592C Method for preparing 'Kawa' soybean milk taken at night for soothing nerves |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238723 Indole derivatives |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238713 Muscarinic agonists |